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Background: Isolated stenosis of the left anterior descending coronary 
artery can be treated with medication, percutaneous transluminal coronary 
angioplasty, or coronary artery bypass grafting. Recently a new treatment 
has been developed, which is called minimally invasive direct coronary 
artery bypass grafting. This new treatment is a modification of the 
conventional bypass operation and is performed through a small antero- 
lateral thoracotomy without cardiopulmonary b pass. Methods: To compare 
minimally invasive bypass with angioplasty, we evaluated in-hospital 
results and 1-year follow-up in 181 consecutive patients with isolated type 
C stenosis of the left anterior descending coronary artery between January 
1995 and July 1996. Of these patients, 71 underwent minimally invasive 
bypass and 110 angioplasty. Preoperative characteristics were not signifi- 
cantly different between the two groups. Results: In-hospital death, peripro- 
cedural myocardial infarction, emergency reoperation by means of conven- 
tional coronary bypass grafting, use of an intraaortic balloon pump, and 
cerebrovascular ccidents were not significantly different between the two 
groups. At 1-year follow-up, survival was not significantly different in the 
two groups (minimally invasive bypass 95.7% +- 0.2% vs angioplasty 95.3% 
-+ 0.2%; p = 0.89), whereas freedom from repeated revascularization was 
significantly more common in the group undergoing minimally invasive 
bypass (bypass 96.9% - 0.2% vs angioplasty 67.6% - 0.5%;p < 0.001). This 
study shows that the need for repeated revascularization, and therefore the 
use of health care resources, is significantly less with minimally invasive 
bypass than with angioplasty in patients with isolated type C stenosis of the 
left anterior descending coronary artery. (J Thorac Cardiovasc Surg 1997; 
114:434-9) 
I solated stenosis of the left anterior descending coronary artery (LAD) is associated with a poor 
prognosis. 1 Both percutaneous transluminal coro- 
nary angioplasty (PTCA) 2 and coronary artery by- 
pass grafting (CABG) with the use of the left 
internal thoracic artery (LITA) 3' 4 are more effective 
than medical treatment in relieving symptoms and 
improving survival. 
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PTCA is considered the method of choice for 
treatment of isolated stenosis of the LAD, because 
of the low impact on the patient, low cost, and good 
early results. However, the results of PTCA for type 
C lesions are poorer than for type A and B lesions. 5
Recently a new surgical method for treatment has 
been developed for the treatment of stenosis of the 
LAD, which is called minimally invasive direct cor- 
onary artery bypass (MICABG). MICABG is a 
radical modification of the conventional CABG and 
is performed through a small anterolateral thoracot- 
omy without cardiopulmonary bypass. 6-9 MICABG 
aims at maintaining the advantages of conventional 
CABG in terms of survival and freedom from 
cardiac events, 4'5, i0, ii while avoiding its disadvan- 
tages, in particular, the midline sternotomy and the 
use of cardiopulmonary b pass. 
Because MICABG is a new technique, its effec- 
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tiveness has not been compared yet with PTCA in 
the treatment of isolated stenosis of the LAD. This 
study was designed to compare MICABG with 
PTCA in a group of consecutive patients with 
isolated type C stenosis of  the LAD, by evaluating 
in-hospital results and 1-year follow-up. 
Patients and methods 
Study design. To compare MICABG with PTCA, we 
evaluated in-hospital results and 1-year clinical follow-up 
in 181 consecutive patients with isolated type C stenosis of 
the LAD who underwent either MICABG or PTCA in the 
University Hospital of Groningen between January 1995 
and July 1996. Because we considered the absence of 
recurrent myocardial ischemia to be a sign of successful 
revascularization in symptomatic patients with one-vessel 
disease, an angiographic follow-up study was obtained 
only in patients with recurrent chest pain and with abnor- 
mal exercise test results. Clinical data were collected in a 
customized atabase used for patient management. Fol- 
low-up was completed on the basis of telephone inter- 
views and was closed on January 1, 1997. 
Patients. From January 1995 onward, 181 consecutive 
patients with angina pectoris, documented myocardial 
ischemia, and isolated type C stenosis 5 of the LAD were 
included in the study. A panel of two cardiologists and two 
cardiac surgeons gave general consensus on the feasibility 
of both MICABG and PTCA. The two treatments were 
then presented to the patients, who were informed of 
MICABG as an alternative treatment to PTCA, which was 
presented as the standard treatment. The final choice of 
treatment was left to the patient, who gave informed 
consent. T]he study was approved by the Institutional 
Review Board of the University Hospital of Groningen. 
Of the 181 consecutive patients, 71 patients underwent 
MICABG and 110 underwent PTCA. All MICABG pro- 
cedures were primary operations and all PTCA proce- 
dures were performed on de novo lesions. All operations 
were elective. Patients with "rescue PTCA" or with acute 
or evolving myocardial infarction were excluded from the 
study. Patients with any associated cardiac disease were 
also excluded from the study. The two treatment groups 
did not differ significantly with regard to preoperative 
characteristics (Table I). 
Technique 
MICABG. A double-lumen endotracheal tube was used 
to deflate the left lung during the procedure. The patient 
was positioned supine and a small rubber cushion was 
placed underneath the left scapula. The left arm was 
elevated above the head. A skin incision of approximately 
8 to 10 cm was made in the fifth intercostal space. Once 
the pleural cavity was opened, the left lung was deflated 
and the LITA was identified by palpation. 
A specia][ly developed wound spreader (IMA Retractor, 
CardioThoracic Systems, Inc., Cupertino, Calif.) was se- 
cured in place. The particular shape of the spreader's 
arms created avisual tunnel toward the LITA through the 
small chest opening, thus facilitating the harvesting of the 
LITA. After the LITA had been harvested, the wound 
spreader was replaced by another spreader (Access Plat- 
Table I. Preoperative data 
MICABG group PTCA group p 
(71 patients) (110 patients) Value 
Age 61.8 _+ 10.2 64.0 _+ 9.9 0.15 
Sex (M/F) 57/14 78/32 0.21 
Hypertension 21 (29.6%) 32 (29.1%) 0.92 
Hypercholesterolemia 22 (31%) 33 (30%) 0.98 
Diabetes 8 (11.3%) 14 (12.7%) 0.95 
COPD 7 (9.9%) 11 (10%) 0.82 
Smoking 20 (28.1%) 23 (20.9%) 0.34 
Obesity 4 (5.6%) 7 (6.4%) 0.90 
Previous MI 26 (36.6%) 41 (37.3%) 0.94 
M/F, Male/female ratio; COPD, chronic obstructive pulmonary disease; 
MI, myocardial nfarction. 
form, CardioThoracic Systems) carrying a coronary artery 
stabilizer (Stabilizer, CardioThoracic Systems). The coro- 
nary artery stabilizer has been designed to immobilize the 
segment of the LAD including the site of the anastomosis. 
Immobilization of the LAD facilitates the performance of
the anastomosis. Then heparin was given (100 IU/kg) and 
the thoracic pedMe was divided. The LAD was sur- 
rounded by two looping 5-0 polypropylene sutures, prox- 
imal and distal to the chosen site for the anastomosis. The 
LAD was opened longitudinally, the two looping sutures 
were pulled up to provid e a bloodless operative field, and 
the LITA-LAD anastomosis was performed with a run- 
ning 7-0 polypropylene suture. To remove excess blood 
from the anastomotic site, we used a blower device in the 
first 20 patients. After that we preferred to use irrigation 
with warm saline solution during the anastomosis (37 ° C). 
Protamine was not given at the end of the procedure. The 
small thoracotomy wound was closed in layers and one 
pleural drain was left in place. To reduce the time of 
ventilatory support, we used a protocol of fast weaning in 
all patients. 
PTCA. PTCA was performed through the right or left 
femoral access route or through the left or right radial 
artery. Guiding catheters in sizes 8F and 6F were used. 
The coronary arteries were cannulated with 0.014-inch 
guide wires, and matched-size monorail-type balloon cath- 
eters were used to dilate the lesions. PTCA was consid- 
ered successful if the stenosis was reduced to less than 
50%, as judged by visual estimation of the post-PTCA 
angiogram, and if ischemia nd/or chest pain and/or flow 
obstruction were absent) Coronary stents were implanted 
either as a bail-out procedure or for treatment of a 
suboptimal balloon angioplasty result. 
Follow-up. The design of the study required only clin- 
ical follow-up. To complete the data collection, we con- 
tacted the patients' attending cardiologists, who were 
responsible for routine follow-up. Four patients were lost 
to follow-up. A second angiogram was performed only in 
patients with recurrent chest pain and with abnormal 
exercise test results. For patients in the PTCA group who 
had a symptomatic restenosis, a second PTCA was rec- 
ommended and conventional CABG was suggested as an 
alternative. For patients in the MICABG group who 
needed repeated revascularization, both PTCA and con- 
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Fig. 1. Survival after PTCA or MICABG. 
Table II. Clinical results 
MICABG group PTCA group p 
(71 patients) (110 patients) Value 
Death 1 (1.4%) 3 (2.7%) 0.34 
PMI 4 (5.6%) 4 (3.6%) 0.24 
In-hospital re-CABG 3 (4.3%) 8 (7.3%) 0.60 
IABP 2 (2.8%) I (0.9%) 0.70 
CVA 1 (1.4%) 1 (0.9%) 0.68 
Hospital stay (days) 4.4 + 1.8 4.4 _+ 5.2 0.33 
Death, in-hospital mortality; PMI,, periprocedural myocardial infarction; 
in-hospital re-CABG, in-hospital urgent or emergency onventional coro- 
nary artery bypass grafting; IABP, intraaortic balloon pump; CVA, cere- 
brovascular ccident. 
ventional CABG were proposed. In both groups the final 
choice of treatment was left to the patient. 
Statistical analysis. All data were processed with the 
use of the SPSS statistical package (SPSS, Inc., Chicago, 
Ill.). All continuous variables are expressed as mean _+ 
standard eviation. 
All tests of significance were two-tailed: X2 and Fisher's 
exact test for discrete variables and analysis of variance 
and Mann-Whitney test for continuous variables. 
The primary end points were in-hospital procedure- 
related cardiac death and in-hospital myocardial infarc- 
tion. Secondary end points were death related to cardiac 
disease at follow-up and repeated revascularization (ei- 
ther PTCA or conventional CABG) for symptomatic 
angina pectoris at follow-up. 
Standard clinical, electrocardiographic, and laboratory 
criteria were used to identify the occurrence of myocardial 
infarction. Repeated revascularization was defined as the 
need for a PTCA or conventional CABG of the LAD. The 
outcomes of MICABG and PTCA were compared accord- 
ing to the intention-to-treat principle. The rates of in- 
hospital complications were compared only among pa- 
tients who actually received the assigned treatment. 
Kaplan-Meier analysis was used to estimate the cumula- 
rive rate of survival (including in-hospital death) and 
repeated revascularization. 12 Survival and freedom from 
repeated revascularization were expressed as cumulative 
data _+ standard error of the mean (95% confidence 
intervals). Kaplan-Meier curves of survival and freedom 
from repeated revascularization were compared by means 
of the log-rank test. 13 
Results 
PTCA group. PTCA was successful in 94 of 110 
patients (stents were used in 15 of these patients). 
PTCA was unsuccessful in the remaining 16 pa- 
tients. Among them, four patients underwent rescue 
(emergency) CABG and four patients underwent 
elective CABG during the hospitalization. 
We recorded three in-hospital deaths. One pa- 
tient died during PTCA, one patient died of acute 
renal insufficiency caused by the contrast medium, 
and one died of ventrieular fibrillation during the 
hospital stay. Four patients had an in-hospital myo- 
cardial infarction. Among them, one patient re- 
quired treatment with an intraaortic balloon pump. 
One patient had a cerebrovascular ccident (tran- 
sient ischemic attack). Six patients refused further 
treatment after the unsuccessful PTCA and were 
treated medically. Mean hospital stay was 4.4 - 5.2 
days. 
MICABG group. MICABG was successful in 69 
of 71 patients. MICABG was converted to conven- 
tional CABG via a midline sternotomy in the re- 
maining two patients, and the anastomosis on the 
LAD was made during cardioplegic arrest. The 
conversion to a midline sternotomy was due to 
difficulties in finding the LAD. A third patient 
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Fig. 2. Freedom from repeated revascularization after PTCA or MICABG. 
underwent emergency CABG via a midline sternot- 
omy on postoperative day 1 after sudden electro- 
cardiographic changes that appeared after extuba- 
tion. This patient received an extra vein graft to the 
LAD. 
We recorded one in-hospital death. The patient in 
question was discharged from our unit on postoper- 
ative day 4 after an uneventful postoperative course 
and was transferred to the internal medicine de- 
partment for continuation of immunosuppressive 
treatment because of a previous liver transplanta- 
tion. He died of acute liver failure 45 days after 
MICABG. Four patients had a perioperative myo- 
cardial infarction: they all were restudied by means 
of angiography on postoperative day 1, and in all 
of them the LITA-LAD anastomosis was patent. 
Two of the four required treatment with an 
intraaortic balloon pump. All in-hospital cardiac 
complications in the MICABG group occurred 
among the first 14 patients. In particular, we 
recorded perioperative myocardial infarctions 
only in the early group of patients treated by 
MICABG, when a blower device was used to 
achieve a bloodless operative field. We have 
therefore related the occurrence of perioperative 
infarction to air embolism in these patients, in the 
absence ,of an angiographically demonstrated mal- 
function of the LITA-LAD anastomosis. This fact 
led us to discontinue the use of a blower device in 
favor of irrigation with warm saline solution 
(37 ° C). One patient had a cerebrovascular cci- 
dent (transient ischemic attack). 
Mean operative time was 91.1 +_ 28.0 minutes 
(range 60 to 230 minutes). Mean time of coronary 
occlusion was 10.7 ± 3.5 minutes (range 5 to 23 
minutes). Mean hospital stay was 4.4 ± 1.8 days 
(range 3 to 11 days). No significant differences in 
in-hospital results were identified between the two 
treatment groups (Table II). 
Follow-up. Mean follow-up was 15.6 ± 5.9 
months. A 98% follow-up was achieved. Two 
patients died at follow-up in the MICABG group, 
2 and 3 months after discharge: one died of 
sudden cardiac death and one of a cerebrovascu- 
lar accident. Two patients died at follow-up in the 
PTCA group, 2 and 5 months after discharge, both 
of sudden cardiac death. At 1-year follow-up, 
survival was not significantly different between the 
two groups (Fig. 1, MICABG 95.7% ± 0.2% vs 
PTCA 95.3% ± 0.2%;p = 0.89), whereas freedom 
from repeated revascularization was significantly 
higher in the MICABG group (Fig. 2, MICABG 
96.9% ± 0.2% vs PTCA 67.6% ± 0.5%; p < 
0.001). In particular, in the MICABG group, two 
patients (3%) underwent PTCA. In one of these 
two patients, the PTCA was performed to dilate a 
stenosis at the anastomotic site, and in the other 
patient he PTCA was performed to dilate a new 
stenosis that developed istal to the site of the 
anastomosis. 
In the PTCA group, 16% of the patients under- 
went a PTCA of the LAD and 17% of the patients 
underwent conventional CABG via a midline ster- 
notomy. 
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Discussion 
This study shows that the need for repeated 
revascularization and therefore the use of health 
care resources i significantly lower after MICABG 
than after PTCA in patients with isolated type C 
stenosis of the LAD. This study also shows that 
1-year survival is not significantly different between 
MICABG and PTCA. Surprisingly, the in-hospital 
results are not significantly different between the 
two groups, and these results should even be evalu- 
ated in the light of a technique-related bias: PTCA 
is a standard technique with established results, 5 
whereas MICABG has just passed its pioneering 
era. Therefore the learning curve may have masked 
a potential difference in in-hospital results in favor 
of MICABG. This observation is supported by the 
fact that all cardiac complications in the MICABG 
group occurred among the first 14 patients. Later 
on, the cardiac morbidity and mortality of MICABG 
dropped to zero and no patient required repeated 
revascularization. 
The question whether PTCA or surgical treat- 
ment is the best option for patients with isolated 
stenosis of the LAD remains controversial, although 
some trials have shown that conventional CABG 
(via a midline sternotomy and with cardiopulmonary 
bypass) may yield better midterm and long-term 
results than PTCA.  14-2° In fact, in these trials the 
risk of cardiac death or myocardial infarction at 
follow-up in patients with single-vessel disease was 
lower for conventional CABG than for PTCA.  14-2° 
In particular, PTCA of the proximal LAD has been 
associated with rates of restenosis that range from 
30% up to 50%.  15' 21-23 The results of PTCA of the 
LAD have been even poorer for type C stenosis. 5 
On the other hand, conventional CABG, although 
having better midterm and long-term results, gener- 
ally causes a longer hospital stay, higher morbidity, 
and higher initial cost of medical care than PTCA. 
The cost of conventional CABG and PTCA is 
primarily dependent on the occurrence of postpro- 
cedural complications, including the recurrence of 
myocardial ischemia at follow-up. 16-1s'23 The re- 
duced use of disposable materials and the shorter 
hospital stay render the initial cost of MICABG 
lower than that of conventional CABG. Later on, 
the greater need for repeated revascularization at
follow-up in the PTCA group causes a further 
increase in use of health care resources compared 
with MICABG. These two observations can favor 
MICABG as an alternative treatment to PTCA for 
patients with isolated type C stenosis of the LAD. 
Two possible objections to this study can be 
raised. The first objection is that we did not use 
stents as a primary treatment in patients undergoing 
PTCA, because at the beginning of the study (Jan- 
uary 1995) primary stent implantation was not con- 
sidered a standard procedure. Recent studies 24' 25 
have shown that primary stent implantation pro- 
vides better results and fewer adverse events at 
follow-up than does conventional PTCA. Still, the 
need for repeated revascularization in patients who 
have had PTCA with primary stent implantation 
remains higher than that reported in this study in 
patients ubjected to MICABG. The second objec- 
tion is that we did not perform a routine anglo- 
graphic follow-up study. The reason for this choice 
is that we considered the absence of recurrent 
myocardial ischemia to be a sign of successful 
revascularization in symptomatic patients with one- 
vessel disease. Future clinical and angiographic pro- 
spective studies comparing primary stent implanta- 
tion and MICABG may further clarify this issue. 
In conclusion, MICABG is more effective than 
PTCA for patients with isolated type C stenosis of 
the LAD at 1-year follow-up. The advantages of 
MICABG in terms of in-hospital results and re- 
duced initial cost may overcome the initial disadvan- 
tages of the conventional CABG via a midline 
sternotomy, while ensuring the best results of surgi- 
cal revascularization in these patients. The potential 
advantages of the LITA graft to the LAD can 
further increase this difference in favor of the 
MICABG in midterm and long-term follow-up. 
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